Inhibition of the growth and metastasis of human colon cancer by restoration of RUNX3 expression in cancer cells

International Journal of Oncology

Volumn 33, Issue 5, 2008, Pages 979-984

  Peng, Zhihai ^a   Tang, Huamei ^a   Wang, Xiaoliang ^a   Zhou, Chongzhi ^a   Fan, Junwei ^a   Wang, Liwei ^a   Jia, Zhiliang ^b   Li, Qiang ^b   Le, Xiangdong ^b   Wei, Daoyan ^b   Xie, Keping ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Colon; Metastasis; RUNX3; Tumor

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR RUNX3; RUNX3 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; COLON TUMOR; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSFECTION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; TIME; TUMOR CELL LINE;

AGED; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; CORE BINDING FACTOR ALPHA 3 SUBUNIT; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM METASTASIS; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 58149176626     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000085     Document Type: Article

References (34)

1. Parkin DM, Bray FJ, Ferlay and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Li M and Gu J: Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol 11: 4685-4688, 2005.
3. Fearon ER and Vogelstein BA: Genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
4. Markowitz SD and Roberts AB: Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 7: 93-102, 1996.
5. Goel A, Arnold CN, Tassone P, et al: Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int J Cancer 112: 754-759, 2004.
6. Li QL, Ito K, Sakakura C, et al: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124, 2002.
7. Ito Y: Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF. Genes Cells 4: 685-686, 1999.
8. Kania MA, Bonner AS, Duffy JB and Gergen JP: The Drosophila segmentation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system. Genes Dev 4: 1701-1713, 1990.
9. Daga A, Karlovich CA, Dumstrei K and Banerjee U: Patterning of cells in the Drosophila eye by Lozenge, which shares homologous domains with AML1. Genes Dev 10: 1194-1205, 1996.
10. Karsenty G and Wagner EF: Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2: 389-406, 2002.
11. Tracey WD and Speck NA: Potential roles for RUNX1 and its orthologs in determining hematopoietic cell fate. Semin Cell Dev Biol 11: 337-342, 2000.
12. Yang S, Wei D, Wang D, et al: In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 18: 705-715, 2003.
13. Westendorf JJ and Hiebert SW: Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia. J Cell Biochem (Suppl 32-33): 51-58, 1999.
14. Ito Y: Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 23: 4198-4208, 2004.
15. Levanon D, Brenner O, Otto F and Groner Y: Runx3 knockouts and stomach cancer. EMBO Rep 4: 560-564, 2003.
16. Levanon D, Bettoun D, Harris-Cerruti C, et al: The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J 21: 3454-3463, 2002.
17. Stewart M, MacKay N, Cameron ER and Neil JC: The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene. J Virol 76: 4364-4369, 2002.
18. Kim R, Trubetskoy A, Suzuki T, et al: Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J Virol 77: 2056-2062, 2003.
19. Wei D, Gong W, Oh SC, et al: Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res 65: 4809-4816, 2005.
20. Ito K, Liu Q, Salto-Tellez M, et al: RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 65: 7743-7750, 2005.
21. Wang L, Wei D, Huang S, et al: Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9: 6371-6380, 2003.
22. Oshimo Y, Oue N, Mitani Y, et al: Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Pathobiology 71: 137-143, 2004.
23. Kim TY, Lee HJ, Hwang KS, et al: Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 84: 479-484, 2004.
24. Miyazono K, Maeda S and Imamura T: Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins. Oncogene 23: 4232-4237, 2004.
25. Kitabayashi I, Yokoyama A, Shimizu K and Ohki M: Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J 17: 2994-3004, 1998.
26. Lee KS, Kim HJ, Li QL, et al: Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20: 8783-8792, 2000.
27. Zhang YW, Yasui N, Ito K, et al: A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 97: 10549-10554, 2000.
28. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
29. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
30. Mithani SK, Balch GC, Shiou SR, et al: Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells. J Surg Res 117: 296-305, 2004.
31. Yamamura Y, Hua X, Bergelson S and Lodish HF: Critical role of Smads and AP-1 complex in transforming growth factor-beta-dependent apoptosis. J Biol Chem 275: 36295-36302, 2000.
32. Schuster N and Krieglstein K: Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 307: 1-14, 2002.
33. Chipuk JE, Bhat M, Hsing AY, Ma J and Danielpour D: Bcl-xL blocks transforming growth factor-beta I-induced apoptosis by inhibiting cytochrome c release and not by directly antagonizing Apaf-1-dependent caspase activation in prostate epithelial cells. J Biol Chem 276: 26614-26621, 2001.
34. Malumbres M and Barbacid M: To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222-231, 2001.